Drugs / Limbal Stem Cell Derived Exosomes
Limbal Stem Cell Derived Exosomes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06543667 | Aug 2024 → Jan 2026 overdue | dry eye syndrome | Iran University of Medical Sciences | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Limbal Stem Cell Derived Exosomes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06543667 ↗ |
| Modality | Other / unclassified | “Exosomes are membrane vesicles secreted by parental cells” NCT06543667 ↗ |
| Route | Topical | “LSC-Exo eye drops 0.15 ml/single eye/one time” NCT06543667 ↗ |